MEDIA RELEASE: May 16, 2017 10:42 PM
‘Tumour-trained’ immune cells – which have the potential to kill cancer cells – have been seen moving from one tumour to another for the first time. The new findings, which were uncovered by scientists at Sydney’s Garvan Institute of Medical Research, shed light on how immune therapies for cancer might work, and suggest new approaches to developing anti-cancer immune therapies.
May 12, 2017 08:00 AM
Garvan researcher Dr Amali Mallawaarachchi has been awarded a grant from the Polycystic Kidney Disease Foundation of Australia to support the development of an improved genomic diagnostic tool for individuals with kidney disease.
May 11, 2017 02:52 PM
History was made in Canberra yesterday, when the Big Heart Project, an initiative of Love Your Sister, raised a remarkable $2.2 million for cancer research at Garvan.
MEDIA RELEASE: May 11, 2017 12:05 AM
Australian scientists have shown, for the first time, that a family of untethered proteins builds up in the cells of children with a rare and serious genetic condition, known as mevalonate kinase deficiency (MKD).
May 09, 2017 06:00 AM
Garvan congratulates Dr Thomas Cox, Dr Simon Junankar, Dr Romain Rouet and Dr Sean Warren, winners of the annual Ridley Ken Davies Award, CHAMP Young Pioneer Award and the Palmer Innovation Prize.
MEDIA RELEASE: May 08, 2017 06:00 AM
Australian women diagnosed with ovarian cancer before 2013, and their families, will be proactively identified and offered genetic testing for the BRCA1 and BRCA2 genes through a new international study, ‘TRACEBACK’.
May 06, 2017 11:14 AM
Last week (April 24-28), immunologists from round the world converged on Whistler (BC, Canada) for a Keystone Meeting on B Cells and T Follicular Helper Cells – the cells in our immune system that are crucial for long-term protection against infection, and for the success of most vaccines.
May 04, 2017 04:07 PM
Garvan congratulates Professor Jonathan Sprent, of the Institute’s Immunology Division, who has been newly elected as a member of the US National Academy of Sciences (NAS). Membership of the NAS is considered one of the highest honours that a scientist can achieve.
Apr 13, 2017 07:03 PM
In this opinion piece in The Australian, Garvan's Executive Director, Professor John Mattick AO FAA says that Australia could be a front runner in precision medicine – but we need to act now.
MEDIA RELEASE: Apr 11, 2017 03:32 PM
Garvan, CSIRO’s Data61, and the Charles Perkins Centre at The University of Sydney are joining forces for a series of events held as part of Vivid Sydney, showcasing visualisations that are transforming how life scientists view data and communicate discoveries.
MEDIA RELEASE: Apr 11, 2017 12:53 PM
Researchers have ‘mapped’ the entire genome of a prostate tumour, revealing previously undetected levels of DNA rearrangements. The findings, from the Garvan Institute of Medical Research, provide an entirely new lens through which to view prostate cancer – and could one day be used to help characterise an individual’s prostate tumour and reveal previously unrecognised information that could influence clinical treatment.
MEDIA RELEASE: Apr 11, 2017 07:22 AM
Today, World Parkinson’s Day marks 200 years since the disease was first identified by Dr James Parkinson.
MEDIA RELEASE: Apr 11, 2017 05:45 AM
Australian scientists have developed a first-of-its-kind model of Parkinson’s disease in zebrafish. In the model, neurodegeneration occurs through a combination of genetic and environmental factors – just as it does in people.
Apr 10, 2017 11:47 AM
The Garvan Institute of Medical Research and the Asan Medical Center Cancer Institute in Seoul, South Korea, have signed a Memorandum of Understanding (MOU), formalising a cooperative relationship between the two institutes in the areas of research, clinical trials and education.
MEDIA RELEASE: Apr 07, 2017 02:00 AM
Western Australia’s Undiagnosed Diseases Program (UDP) has acquired Patient Archive clinical phenotyping software from the Garvan Institute of Medical Research.
MEDIA RELEASE: Apr 06, 2017 04:00 AM
Australian scientists have uncovered a promising new approach to treating pancreatic cancer, by targeting the tissue around the tumour to make it ‘softer’ and more responsive to chemotherapy. The findings are published today in Science Translational Medicine.
MEDIA RELEASE: Mar 28, 2017 04:00 AM
The Garvan Institute of Medical Research and the Centre for Pattern Recognition and Data Analytics (PRaDA) at Deakin University will today launch the Garvan-Deakin Program in Advanced Genomic Investigation (PAGI).
Mar 24, 2017 03:09 PM
Worlds collide in the landmark Drug Development Conference 2017 which brings together diverse parties that share one aim: to accelerate the delivery of new cancer drugs to patients.
Mar 23, 2017 03:25 PM
Garvan congratulates Associate Professor Elgene Lim, who is one of two inaugural recipients of the National Breast Cancer Foundation Endowed Chair Program.
Mar 02, 2017 12:00 AM
Researchers from Garvan’s Cancer Division were last night awarded five Project Grants from Cancer Council NSW.